The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 3,753,831 | 33,712 | SH | SOLE | 33,712 | 0 | 0 | |||
| ALUMIS INC | COM | 022307102 | 3,678,107 | 166,959 | SH | SOLE | 166,959 | 0 | 0 | |||
| AN2 THERAPEUTICS INC | COM | 037326105 | 1,799,997 | 526,315 | SH | SOLE | 526,315 | 0 | 0 | |||
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 3,462,530 | 113,899 | SH | SOLE | 113,899 | 0 | 0 | |||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 5,778,850 | 1,045,000 | SH | SOLE | 1,045,000 | 0 | 0 | |||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 2,645,000 | 500,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 2,645,000 | 500,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 4,230,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 5,071,500 | 161,000 | SH | SOLE | 161,000 | 0 | 0 | |||
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 4,781,115 | 660,375 | SH | SOLE | 660,375 | 0 | 0 | |||
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | 2,226,000 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | |||
| INVENTIVA SA | ADS | 46124U107 | 4,136,415 | 745,300 | SH | SOLE | 745,300 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 1,392,500 | 250,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| MAZE THERAPEUTICS INC | COM | 578784100 | 2,985,000 | 100,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | 9,974,388 | 1,655,500 | SH | SOLE | 1,655,500 | 0 | 0 | |||
| OVID THERAPEUTICS INC | COM | 690469101 | 6,256,979 | 2,818,459 | SH | SOLE | 2,818,459 | 0 | 0 | |||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 3,863,743 | 926,557 | SH | SOLE | 926,557 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 10,571,054 | 32,810 | SH | SOLE | 32,810 | 0 | 0 | |||
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | 5,260,581 | 414,219 | SH | SOLE | 414,219 | 0 | 0 | |||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 1,465,254 | 210,525 | SH | SOLE | 210,525 | 0 | 0 | |||
| REPLIMUNE GROUP INC | COM | 76029N106 | 1,888,785 | 246,900 | SH | Call | SOLE | 0 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 6,696,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 6,696,000 | 200,000 | SH | Put | SOLE | 0 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 5,522,213 | 766,974 | SH | SOLE | 766,974 | 0 | 0 | |||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 5,672,259 | 80,859 | SH | SOLE | 80,859 | 0 | 0 | |||
| UNIQURE NV | SHS | N90064101 | 4,905,000 | 300,000 | SH | Call | SOLE | 0 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 3,634,190 | 202,124 | SH | SOLE | 202,124 | 0 | 0 | |||
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | 2,821,890 | 817,939 | SH | SOLE | 817,939 | 0 | 0 | |||